Faes Farma (HAM:FFEA) Construction In Progress: €1.8 Mil (As of Dec. 2025)


HAM:FFEA Faes Farma SA HAM:FFEA
95 GF Score
Price €4.54
GF Value €5.02
! 6 Warning Signs
View Full Analysis

What is Faes Farma Construction In Progress?

Faes Farma HAM:FFEA -0.55% 95 Construction In Progress is €1.8 Mil as of Dec. 2025. GuruFocus rates HAM:FFEA with a GF Score™ of 95/100 and a GF Value™ of €5.02. The stock has 6 warning signs investors should review.

Faes Farma's quarterly construction in progress declined from Dec. 2024 (€1.1 Mil) to Jun. 2025 (€0.0 Mil) but then increased from Jun. 2025 (€0.0 Mil) to Dec. 2025 (€1.8 Mil).

Faes Farma's annual construction in progress declined from Dec. 2023 (€177.2 Mil) to Dec. 2024 (€1.1 Mil) but then increased from Dec. 2024 (€1.1 Mil) to Dec. 2025 (€1.8 Mil).

Faes Farma Construction In Progress Historical Data

* Premium members only.

The historical data trend for Faes Farma's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Faes Farma Construction In Progress Chart

Faes Farma Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.85 97.66 177.23 1.11 1.81

Faes Farma Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 177.23 190.77 1.11 0.00 1.81
HAM:FFEA
95GF Score
Faes Farma SA HAM:FFEA
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Faes Farma Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of €1.8 Mil mean?
Faes Farma (HAM:FFEA) has a Construction In Progress of €1.8 Mil as of Dec. 2025. Construction in Progress records the amount of construction work that is not complete. View historical data on Faes Farma and its competitors.
Is Faes Farma's Construction In Progress too high?
Faes Farma's current Construction In Progress is €1.8 Mil. Overall, Faes Farma has a GF Score™ of 95/100, reflecting its overall financial health beyond just this single metric.
How does Faes Farma's Construction In Progress compare to ZTS and UTHR?
Faes Farma's Construction In Progress of €1.8 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Drug Manufacturers company?
A good Construction In Progress depends on the Drug Manufacturers industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Faes Farma and its competitors. Faes Farma's current Construction In Progress is €1.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Faes Farma stock overvalued right now?
Faes Farma (HAM:FFEA) has a current Construction In Progress of €1.8 Mil. The stock's GF Value™ is €5.02, compared to a current price of €4.54 — trading 9.6% below its estimated fair value. The current Construction In Progress is €1.8 Mil. Faes Farma's overall GF Score™ is 95/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Faes Farma (HAM:FFEA), the current Construction In Progress is €1.8 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Faes Farma (HAM:FFEA) Overvalued in 2026?

Based on GuruFocus' analysis, Faes Farma stock appears to be undervalued. The current stock price of €4.54 is trading 9.6% below its estimated GF Value™ of €5.02.

Key valuation signals for HAM:FFEA:

  • Construction In Progress: €1.8 Mil
  • GF Value™: €5.02 vs. price of €4.54 (9.6% below fair value)
  • GF Score™: 95/100 with 6 warning signs

No single metric tells the full story. See the HAM:FFEA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Faes Farma Business Description

Address Avenida Autonomia, 10, Leioa, Vizcaya, ESP, 48940
Faes Farma SA purpose is manufacturing and selling all kinds of chemical and pharmaceutical products, foodstuffs, cosmetics, dietetics and medicinal plants, as well as acquiring, purchasing, disposing of, investing in, holding, using, managing, administering, marketing and leasing corporations, securities and real estate, patents, trademarks and registered brands and equity interests. It is mainly engaged in the manufacture and sale of pharmaceutical products, as well as in the manufacture and sale of animal nutrition and health products. Its segments are Pharmaceutical and healthcare specialities, Animal nutrition and health, and Other segments. It generates majority of revenue from Pharmaceutical and healthcare specialities. It operates mainly in domestic and international markets.
95GF Score

Get the complete analysis for HAM:FFEA

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.54
Price
€5.02
GF Value